openPR Logo
Press release

Orphan Diseases Market to grow over USD 576.9 billion revenue with stable CAGR of 24.9% by 2022

06-09-2017 02:31 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Market Synopsis of Global Orphan diseases Market:
Market Scenario:
Global orphan diseases market also known as rare disease is growing rapidly. It affects a very small percentage of the global population. Most of the orphan diseases are genetic and is remains throughout the life of the patient. There are no exact number of diseases available but approximately there are about 7000 different rare diseases and disorders throughout the globe. Global orphan diseases market is expected to grow at the average CAGR of 24.9% constantly throughout this period 2015-2022. It is also expected that this market which was US$ 121.6 billion in 2015 will grow to US$ 576.9 billion by 2022. . However due to lack of awareness, correct diagnosis, correct treatments and availability of healthcare facilities are inhibiting the growth of the global orphan diseases market.

Key Players for Global Orphan diseases Market:
• Bristol-Myers Squibb Company (US),
• Novartis AG (Switzerland),
• CELGENE CORPORATION (US),
• F. Hoffmann-La Roche Ltd (Switzerland),
• Pfizer Inc. (US),
• Alexion (US),
• Sanofi (French),
• Vertex Pharmaceuticals Incorporated (US),
• GlaxoSmithKline plc. (UK),
• Merck & Co., Inc (US),
• AbbVie Inc. (US)

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2547

Segments:
Global orphan diseases market has been segmented
On the basis of types of diseases which includes autoimmune disorders, genetic disorders, blood disorders, cancer, growth disorder, cardiovascular diseases, neurological disorders, respiratory disorders, digestive disorders, eye disorders and others.
On the basis of treatment type it segmented into gene therapy, cell therapy, drug therapy and others.
On the basis of end user the market is segmented into hospital and clinics, research laboratory and others.

Intended Audience
• Hospitals and clinics
• Orphan diseases drug manufacturers and suppliers
• Government and independent regulatory authorities
• Research and development (R&D) companies
• Market research and consulting service providers
• Medical research laboratories
• Potential investors

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Orphan Diseases Market- Global Forecast To 2022”

Browse full Report @ https://www.marketresearchfuture.com/reports/orphan-diseases-market

Table of Content

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5 Market Factor Analysis
Continue……….

The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.

Related Report
Global Prostate cancer Research, by product type hormone therapy, targeted therapies, therapeutic vaccines and others), end users (hospitals, clinics and others) - Forecast to 2027.Know more about this report @ https://www.marketresearchfuture.com/reports/global-prostate-cancer-market-research-report-forecast-to-2027

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Orphan Diseases Market to grow over USD 576.9 billion revenue with stable CAGR of 24.9% by 2022 here

News-ID: 571593 • Views:

More Releases from Market Research Future

Expense Tracker Apps Market Growth, Trends, and Future Outlook to 2035
Expense Tracker Apps Market Growth, Trends, and Future Outlook to 2035
Market Overview The Expense Tracker Apps Market has emerged as an important segment of the global fintech ecosystem as individuals and organizations increasingly rely on digital tools to manage financial activities. Expense tracker applications allow users to record spending, categorize transactions, monitor budgets, and generate financial insights in real time. These apps are designed for both personal finance management and business expense monitoring, enabling users to gain better control over financial
WLAN Market Growth Analysis, Trends, and Future Forecast (2026-2035)
WLAN Market Growth Analysis, Trends, and Future Forecast (2026-2035)
Market Overview The WLAN Market, or Wireless Local Area Network market, refers to the global ecosystem surrounding wireless networking technologies that enable devices to connect and communicate over radio frequencies without the need for cables. WLAN solutions have become ubiquitous across corporate enterprises, educational institutions, healthcare facilities, retail environments, industrial complexes, and public spaces, enabling seamless connectivity for smartphones, laptops, tablets, IoT devices, and other endpoints. The market has witnessed significant
Embedded Graphical User Interface (GUI) Development Software Market - Growth, Trends & Future Prospects
Embedded Graphical User Interface (GUI) Development Software Market - Growth, Tr …
Market Overview The Embedded Graphical User Interface (GUI) Development Software Market refers to software tools and platforms designed to create, deploy, and manage graphical interfaces for embedded systems. These systems are integrated within hardware devices and perform dedicated functions ranging from automotive infotainment consoles and medical devices to consumer electronics and industrial machines. Unlike traditional desktop or mobile GUIs, embedded GUIs are optimized for resource-constrained environments that demand high performance, low
Smart Lock Market Growth, Trends, and Future Opportunities (2026-2035)
Market Overview The Smart Lock Market refers to the global ecosystem of advanced locking devices that use digital technologies to provide secure, convenient, and connected access control solutions. Unlike traditional mechanical locks, smart locks enable keyless entry, remote access control, and integration with home automation systems using wireless communication technologies such as Bluetooth, Wi-Fi, Z-Wave, and NFC. Smart locks have found wide adoption in residential, commercial, and industrial settings due to

All 5 Releases


More Releases for Orphan

Acquired Orphan Blood Disease Market
Acquired Orphan Blood Disease Market to reach over USD 18.93 billion by the year 2031 - Exclusive Report by InsightAce Analytic According to a new report by InsightAce Analytic, the "Acquired Orphan Blood Disease Market" in terms of revenue was estimated to be worth $8.65 billion in 2023 and is poised to reach $18.93 billion by 2031, growing at a CAGR of 10.47% from 2024 to 2031. Get Free Access to
Orphan Drugs Market Size to Hit $3199.3 Billion by 2028 | Orphan Drugs Industry …
Market Overview: According to our experience research team, Orphan Drugs Market was valued at USD 112.36 Billion in 2021, and the global Orphan Drugs industry is projected to reach a value of USD 3199.3 Billion by 2028, at a CAGR of 7.4% during the forecast period 2022-2028 Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy &
Orphan Drug Pipeline & Regulatory Insight 2025
Orphan Drug Pipeline & Regulatory Insight 2025" Report Highlights: Global Orphan Drug Market Overview: US$ 260 Billion Opportunity Global Orphan Drug market by Segment Regulatory Landscape: USA, Europe & Asia Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia Global Orphan Drug Clinical Pipeline Insight: 973 Drugs Marketed Orphan Drug Clinical Insight: 366 Drugs The global orphan drug market opportunity is expected to surpass US$ 260 Billion by 2025 as per
US Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.
Europe Orphan Drugs Pipeline Analysis
“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug
Global Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the